Adolescent Projections During Transition in Prader-Willi Syndrome
- Conditions
- Prader-Willi Syndrome
- Interventions
- Behavioral: Phone interview
- Registration Number
- NCT06279052
- Lead Sponsor
- University Hospital, Toulouse
- Brief Summary
Single-center, cross-sectional qualitative study seeking to collect the experience of adolescence and the transition to adulthood of people affected by Prader-Willi syndrome in a population. To do this, the present will carry out a qualitative study with a reflexive thematic analysis of the data collected through semi-structured interviews using an interview guide.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 20
- Patients with genetically confirmed Prader-Willi syndrome
- Patients affiliated or beneficiaries of a social security system
- Patients known and followed by the reference center, presenting sufficient intellectual skills to answer the interview questions
- Refusal of family participation (if minor)
- Refusal of participation by the patient or his guardian (if of legal age)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Phone interview Phone interview Patients will then be contacted by the investigator to arrange a telephone appointment date. On the day of the telephone appointment, the psychiatry intern will call the patient to conduct the interview which will last between 30 and 60 minutes. At the end of the telephone interview, the patient's participation in the research will end.
- Primary Outcome Measures
Name Time Method Experience of the disease and aspirations regarding the future 1 hour The main objective of this study is to explore their experience of the disease and their aspirations regarding their future in a population of older adolescents and young adults with Prader-Willi syndrome. A questionnaire created by the clinical investigator containing personal questions will be applied to all patients. There is no scale.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
CHU de Toulouse
🇫🇷Toulouse, France